All looks good until you get to the last line
"Our sales pipeline continues to build, however some opportunities are shifting to FY23. We are also seeing operating costs increasing at a similar rate to revenue. FY22 EBITDA will be in the range of $45m to $50m and we are now revising our guidance for FY22 NPAT to be in the range of $25m to $30m, which is below previous guidance provided at the November 2021 AGM"
a profit downgrade. Going to be a very poor 2nd half.
Cashflow looks good until you see the amount of capitalised software 11.3mil an increase of about 40% from last year.
Will be interesting to see what the market thinks as it has already dropped in price a lot over the last few months
- Forums
- ASX - By Stock
- BVS
- Ann: 1H22 Results Announcement
Ann: 1H22 Results Announcement, page-3
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add BVS (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
0.033(3.14%) |
Mkt cap ! $474.1M |
Open | High | Low | Value | Volume |
$1.04 | $1.07 | $1.04 | $556.8K | 528.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 4143 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 22672 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 4403 | 1.065 |
8 | 17639 | 1.060 |
6 | 6967 | 1.055 |
5 | 7784 | 1.050 |
4 | 5231 | 1.045 |
Price($) | Vol. | No. |
---|---|---|
1.070 | 23281 | 10 |
1.075 | 13062 | 5 |
1.080 | 21193 | 6 |
1.090 | 156 | 2 |
1.095 | 17338 | 5 |
Last trade - 15.56pm 12/07/2024 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |